Skip to main content
. 2019 Mar 21;20(6):1426. doi: 10.3390/ijms20061426
ALK Anaplastic lymphoma kinase
AP-1 Activator protein-1
ATM Ataxia telangiectasia mutated
BC Breast cancer
BMK-1 Big mitogen-activated protein kinase 1
BNIP3 BCL2 interacting protein 3
BNIP3L BNIP3 like
CCA Cholangiocarcinoma
CCRC Clear cell renal carcinoma
CDKi Cyclin-dependent protein kinase inhibitor
CML Chronic myeloid leukemia
COX2 Cyclooxygenase 2
CRC Colorectal cancer
DDIAS DNA-damage-induced apoptosis suppressor
EGF Epidermal growth factor
E-cad E-cadherin
EMT Epithelial-to-mesenchymal transition
ERK5 Extracellular signal-regulated kinase 5
ERα Estrogen receptor α
FAK Focal adhesion kinase
FGF Fibroblast growth factor
GSK3 Glycogen synthase kinase 3
HCC Hepatocellular carcinoma
HGF Hepatocyte growth factor
IL Interleukin
MAPK Mitogen-activated protein kinase family
MEF-2 Myocyte enhancer factor 2
MHC-I Major histocompatibility complex class I
MM Multiple myeloma
MMP Matrix metalloproteinase
NF-κB Nuclear factor kappa-light-chain-enhancer of activated B cells
NLS Nuclear localization signal
OS Osteosarcoma
OXPHOS Oxidative phosphorylation
PC Prostate cancer
PDAC Pancreatic ductal adenocarcinoma
PDGF Platelet-derived growth factor
PI3K PhosphoInositide 3-kinase
SATB2 Special AT-rich sequence-binding protein 2
SGK Serum/glucocorticoid-regulated kinase
STAT3 Signal transducer and activator of transcription 3
TAM Tumor-associated macrophages
TGF-β Transforming growth factor β
TNBC Triple-negative breast cancer
TNFα Tumor necrosis factor α
TβRI TGF-β receptor type I
VEGF Vascular endothelial growth factor
Vim Vimentin